biotech: Private hospitals in talks with Bharat Biotech for intranasal Covid-19 vaccine
Non-public hospitals have initiated discussions with Bharat Biotech to obtain small portions of its intranasal Covid-19 vaccine, which the federal ...
Non-public hospitals have initiated discussions with Bharat Biotech to obtain small portions of its intranasal Covid-19 vaccine, which the federal ...
The Topic Skilled Committee (SEC) below India's drug regulator will quickly evaluate Bharat Biotech's utility for approval of its intranasal ...
HYDERABAD: Bharat Biotech Worldwide Restricted (BBIL) on Monday mentioned its intranasal Covid-19 vaccine BBV154 has proved to be protected, well-tolerated, ...
Bharat Biotech, which is engaged on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if ...
The Nationwide Technical Advisory Group on Immunisation (NTAGI) is more likely to evaluation security and efficacy knowledge of India's first ...
Copyright © 2022 Asia Today.